HUP0300682A2 - Dalfopristin/kinupristin kombinációit cefpirommal együtt tartalmazó gyógyszerkészítmények - Google Patents
Dalfopristin/kinupristin kombinációit cefpirommal együtt tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0300682A2 HUP0300682A2 HU0300682A HUP0300682A HUP0300682A2 HU P0300682 A2 HUP0300682 A2 HU P0300682A2 HU 0300682 A HU0300682 A HU 0300682A HU P0300682 A HUP0300682 A HU P0300682A HU P0300682 A2 HUP0300682 A2 HU P0300682A2
- Authority
- HU
- Hungary
- Prior art keywords
- cefpirome
- dalfopristine
- quinupristine
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- DKOQGJHPHLTOJR-WHRDSVKCSA-N cefpirome Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DKOQGJHPHLTOJR-WHRDSVKCSA-N 0.000 title abstract 2
- 229960000466 cefpirome Drugs 0.000 title abstract 2
- SUYRLXYYZQTJHF-VMBLUXKRSA-N dalfopristin Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1 SUYRLXYYZQTJHF-VMBLUXKRSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 title 1
- PPKJUHVNTMYXOD-PZGPJMECSA-N c49ws9n75l Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O PPKJUHVNTMYXOD-PZGPJMECSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 229940052337 quinupristin/dalfopristin Drugs 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Thyristors (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A találmány tárgyát cefpirommal együtt alkalmazható szinergikus hatásúkinupristin/dalfopristin kombinációk, valamint ezeket tartalmazókompozíciók és kiszerelési készletek képezik. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0010245A FR2812549B1 (fr) | 2000-08-03 | 2000-08-03 | Associations dalfopristine/quinupristine avec le cefpirome |
| PCT/FR2001/002520 WO2002011751A2 (fr) | 2000-08-03 | 2001-08-02 | Associations dalfopristine/quinupristine avec le cefpirome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0300682A2 true HUP0300682A2 (hu) | 2003-08-28 |
| HUP0300682A3 HUP0300682A3 (en) | 2004-09-28 |
| HU227455B1 HU227455B1 (en) | 2011-06-28 |
Family
ID=8853264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300682A HU227455B1 (en) | 2000-08-03 | 2001-08-02 | Pharmaceutical compositions containing combinations of dalfopristine/quinupristine with cefpirome |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US7005416B2 (hu) |
| EP (1) | EP1313500B1 (hu) |
| JP (1) | JP2004505926A (hu) |
| KR (1) | KR100808715B1 (hu) |
| CN (1) | CN1256982C (hu) |
| AR (1) | AR033992A1 (hu) |
| AT (1) | ATE279204T1 (hu) |
| AU (2) | AU2001284095B2 (hu) |
| BR (1) | BR0112897A (hu) |
| CA (1) | CA2418023A1 (hu) |
| CZ (1) | CZ2003290A3 (hu) |
| DE (1) | DE60106463T2 (hu) |
| DK (1) | DK1313500T3 (hu) |
| EA (1) | EA007713B1 (hu) |
| ES (1) | ES2230358T3 (hu) |
| FR (1) | FR2812549B1 (hu) |
| HU (1) | HU227455B1 (hu) |
| IL (1) | IL154237A0 (hu) |
| MX (1) | MXPA03000959A (hu) |
| NO (1) | NO20030483L (hu) |
| NZ (1) | NZ523982A (hu) |
| PE (1) | PE20020264A1 (hu) |
| PL (1) | PL204278B1 (hu) |
| PT (1) | PT1313500E (hu) |
| SK (1) | SK1202003A3 (hu) |
| TN (1) | TNSN01116A1 (hu) |
| WO (1) | WO2002011751A2 (hu) |
| ZA (1) | ZA200300903B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107420042B (zh) * | 2017-09-25 | 2023-03-31 | 中国地质大学（武汉） | 一种基于六自由度并联机构的海底钻机自动调平系统 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0867676A (ja) * | 1994-03-30 | 1996-03-12 | Eisai Kagaku Kk | 保護アミノチアゾリル酢酸誘導体 |
| US5464616A (en) * | 1994-08-04 | 1995-11-07 | Synphar Laboratories, Ind. | 6β-substituted penicillanic acids as beta-lactamase inhibitors |
| US5686441A (en) * | 1995-08-04 | 1997-11-11 | Syphar Laboratories, Inc. | Penam sulfones as β-lactamase inhibitors |
| FR2755857B1 (fr) * | 1996-11-19 | 1998-12-24 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
| US6187746B1 (en) * | 1997-12-16 | 2001-02-13 | Rhone-Poulenc Rorer S.A. | Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof |
| US6465428B1 (en) * | 1999-08-27 | 2002-10-15 | Aventis Pharma S.A. | Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime |
-
2000
- 2000-08-03 FR FR0010245A patent/FR2812549B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-26 PE PE2001000759A patent/PE20020264A1/es not_active Application Discontinuation
- 2001-08-01 AR ARP010103684A patent/AR033992A1/es unknown
- 2001-08-01 TN TNTNSN01116A patent/TNSN01116A1/fr unknown
- 2001-08-02 HU HU0300682A patent/HU227455B1/hu not_active IP Right Cessation
- 2001-08-02 JP JP2002517086A patent/JP2004505926A/ja active Pending
- 2001-08-02 CA CA002418023A patent/CA2418023A1/fr not_active Abandoned
- 2001-08-02 CN CNB018148573A patent/CN1256982C/zh not_active Expired - Fee Related
- 2001-08-02 AT AT01963045T patent/ATE279204T1/de not_active IP Right Cessation
- 2001-08-02 AU AU2001284095A patent/AU2001284095B2/en not_active Ceased
- 2001-08-02 CZ CZ2003290A patent/CZ2003290A3/cs unknown
- 2001-08-02 SK SK120-2003A patent/SK1202003A3/sk unknown
- 2001-08-02 IL IL15423701A patent/IL154237A0/xx unknown
- 2001-08-02 DE DE60106463T patent/DE60106463T2/de not_active Expired - Lifetime
- 2001-08-02 EA EA200300214A patent/EA007713B1/ru unknown
- 2001-08-02 PT PT01963045T patent/PT1313500E/pt unknown
- 2001-08-02 KR KR1020037001575A patent/KR100808715B1/ko not_active Expired - Lifetime
- 2001-08-02 WO PCT/FR2001/002520 patent/WO2002011751A2/fr not_active Ceased
- 2001-08-02 MX MXPA03000959A patent/MXPA03000959A/es unknown
- 2001-08-02 ES ES01963045T patent/ES2230358T3/es not_active Expired - Lifetime
- 2001-08-02 NZ NZ523982A patent/NZ523982A/en not_active IP Right Cessation
- 2001-08-02 PL PL365075A patent/PL204278B1/pl not_active IP Right Cessation
- 2001-08-02 BR BR0112897-3A patent/BR0112897A/pt not_active IP Right Cessation
- 2001-08-02 AU AU8409501A patent/AU8409501A/xx active Pending
- 2001-08-02 EP EP01963045A patent/EP1313500B1/fr not_active Expired - Lifetime
- 2001-08-02 DK DK01963045T patent/DK1313500T3/da active
- 2001-08-03 US US09/920,810 patent/US7005416B2/en not_active Expired - Lifetime
-
2003
- 2003-01-30 NO NO20030483A patent/NO20030483L/no not_active Application Discontinuation
- 2003-01-31 ZA ZA200300903A patent/ZA200300903B/en unknown
-
2006
- 2006-01-04 US US11/325,919 patent/US20060122103A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
| TR200401264T4 (tr) | CB1-reseptör-antagonistiyle-sibütramin birleşimi, bunları içeren farmasötik-bileşimler ve obezite tedavisinde kullanımları. | |
| NO20031672D0 (no) | Aza- og polyaza-naftalenylkarboksamider for anvendelse som HIV-integraseinhibitorer | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
| PT1372624E (pt) | Medicamento baseado em tramadol | |
| NO20054103L (no) | Dispenseringsanordninger | |
| MXPA05012929A (es) | Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion. | |
| DE60120712D1 (en) | Kallikrein gen | |
| HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
| MXPA03010158A (es) | Sulfonamidas. | |
| SI1404304T1 (sl) | Tableta, obsegajoča cetirizin in psevdoefedrin | |
| HUP0400438A3 (en) | Broadspectrum 2-amino-benzoxazole-6-sulfonamides, their use as hiv protease inhibitor and pharmaceutical compositions containing them | |
| NO20063393L (no) | Farmasoytiske preparater | |
| HUP0401733A3 (en) | Cyclic amine-derivatives and pharmaceutical compositions containing them | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| HUP0303469A3 (en) | Phtalazinon-derivatives, their use and pharmaceutical compositions containing them | |
| PT1259261E (pt) | Composicoes farmaceuticas que compreendem terbinafina | |
| HUP0300682A2 (hu) | Dalfopristin/kinupristin kombinációit cefpirommal együtt tartalmazó gyógyszerkészítmények | |
| IL173929A0 (en) | Analogues of kahalalide f and pharmaceutical compositions containing the same | |
| DK1273301T3 (da) | Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration | |
| ZA200502464B (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome. | |
| HRP20050611B1 (hr) | Kombinacijski lijek | |
| PL1615656T3 (pl) | Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje | |
| NO20044700L (no) | Ny assoiasjon av et antitrombotisk middel og aspirin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NF4A | Restoration of patent protection | ||
| MM4A | Lapse of definitive patent protection due to non-payment of fees |